Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04058249 · ClinicalTrials.gov registry record · NA
Accelerated Theta Burst Stimulation for Inpatients With Bipolar Disorder
A NA study, sponsored by Stanford University.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT04058249: Clinical Trial NA study, sponsored by Stanford University.
NCT04058249 is a NA study that was terminated before completion, run by Stanford University. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04058249, a NA study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
This study evaluates the efficacy of an accelerated schedule of theta-burst stimulation for treating manic episodes in bipolar disorder. In this open-label study, all participants will receive accelerated theta-burst stimulation.
Interventions
- DEVICE Accelerated intermittent theta-burst stimulation over right DLPFC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2019-11-01 |
| Est. Completion | 2021-12-20 |
| Phase | NA |
Why NCT04058249 stopped before completion
NCT04058249 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Accelerated intermittent theta-burst stimulation over right DLPFC is the first listed.
NCT04058249 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04058249 about?
NCT04058249 is a clinical study titled "Accelerated Theta Burst Stimulation for Inpatients With Bipolar Disorder". This study evaluates the efficacy of an accelerated schedule of theta-burst stimulation for treating manic episodes in bipolar disorder. In this open-label study, all participants will receive accelerated theta-burst stimulation.
What is the current status of trial NCT04058249?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2019-11-01. Estimated completion is 2021-12-20.
What interventions are being tested in trial NCT04058249?
The interventions under investigation include: Accelerated intermittent theta-burst stimulation over right DLPFC (DEVICE).
Who is sponsoring clinical trial NCT04058249?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04058249's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI